Pacira BioSciences (PCRX) News Today $26.66 +0.01 (+0.04%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$26.64 -0.02 (-0.06%) As of 09/19/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Pacira BioSciences (PCRX): Evaluating Valuation After Recent Share Price MomentumSeptember 17 at 5:22 PM | finance.yahoo.comRhumbline Advisers Sells 9,754 Shares of Pacira BioSciences, Inc. $PCRXSeptember 17 at 3:28 AM | marketbeat.com51,764 Shares in Pacira BioSciences, Inc. $PCRX Bought by Caxton Associates LLPSeptember 12, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Boosts Stock Position in Pacira BioSciences, Inc. $PCRXSeptember 9, 2025 | marketbeat.comPacira reports inducement grants under Nasdaq listing ruleSeptember 6, 2025 | msn.comBridgeway Capital Management LLC Buys 69,744 Shares of Pacira BioSciences, Inc. $PCRXSeptember 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Takes $32.51 Million Position in Pacira BioSciences, Inc. $PCRXSeptember 6, 2025 | marketbeat.comRafferty Asset Management LLC Takes $251,000 Position in Pacira BioSciences, Inc. $PCRXSeptember 6, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Hits New 1-Year High - Here's What HappenedSeptember 5, 2025 | marketbeat.comPacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 5, 2025 | globenewswire.comPDT Partners LLC Has $5.14 Million Stock Position in Pacira BioSciences, Inc. $PCRXSeptember 3, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 2, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Acquired by Doma Perpetual Capital Management LLCSeptember 1, 2025 | marketbeat.com9,457 Shares in Pacira BioSciences, Inc. $PCRX Acquired by FORA Capital LLCSeptember 1, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Holdings Lifted by Walleye Capital LLCAugust 30, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Bought by Wellington Management Group LLPAugust 29, 2025 | marketbeat.comQuantbot Technologies LP Purchases 24,102 Shares of Pacira BioSciences, Inc. $PCRXAugust 28, 2025 | marketbeat.comMartingale Asset Management L P Takes Position in Pacira BioSciences, Inc. $PCRXAugust 27, 2025 | marketbeat.comAmerican Century Companies Inc. Increases Holdings in Pacira BioSciences, Inc. $PCRXAugust 27, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Holdings in Pacira BioSciences, Inc. $PCRXAugust 26, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Bought by Invesco Ltd.August 25, 2025 | marketbeat.comNuveen LLC Makes New Investment in Pacira BioSciences, Inc. $PCRXAugust 24, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Sold by Vanguard Group Inc.August 24, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Bought by Public Sector Pension Investment BoardAugust 19, 2025 | marketbeat.comDeutsche Bank AG Trims Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 17, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.August 15, 2025 | marketbeat.comNatixis Advisors LLC Invests $327,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 14, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Director Marcelo Bigal Sells 4,912 SharesAugust 12, 2025 | marketbeat.comMarcelo Bigal Sells 4,912 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) StockAugust 12, 2025 | insidertrades.comPacira BioSciences, Inc. (NASDAQ:PCRX) Stock Position Lifted by Global Alpha Capital Management Ltd.August 11, 2025 | marketbeat.comGagnon Securities LLC Has $7.66 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 8, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Hold" from AnalystsAugust 7, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Releases Earnings Results, Misses Expectations By $0.26 EPSAugust 6, 2025 | marketbeat.comPacira outlines narrowed $730M–$750M revenue guidance and increased margin targets as J&J ZILRETTA partnership takes shapeAugust 6, 2025 | msn.comPacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comPacira BioSciences, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comPacira reports Q2 EPS 74c, consensus 71cAugust 6, 2025 | msn.comPacira (PCRX) Tops Q2 Earnings EstimatesAugust 6, 2025 | msn.comInsights Ahead: Pacira BioSciences's Quarterly EarningsAugust 6, 2025 | benzinga.comPacira BioSciences Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comWhat To Expect From Pacira BioSciences Inc (PCRX) Q2 2025 EarningsAugust 4, 2025 | finance.yahoo.comPhocas Financial Corp. Acquires Shares of 142,443 Pacira BioSciences, Inc. (NASDAQ:PCRX)August 4, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Banco Santander S.A.August 4, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 4, 2025 | marketbeat.comJefferies Financial Group Inc. Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 3, 2025 | marketbeat.comPacira BioSciences: Worth Pondering, Strong Balance SheetJuly 29, 2025 | seekingalpha.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Pacer Advisors Inc.July 27, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Victory Capital Management Inc.July 27, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Stock Rating Upgraded by Truist FinancialJuly 26, 2025 | marketbeat.com Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCRX Media Mentions By Week PCRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼1.170.78▲Average Medical News Sentiment PCRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼29▲PCRX Articles Average Week Get the Latest News and Ratings for PCRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
